Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Exec Chat: ResMed's CEO Mick Farrell Outlines 2025 Strategy For 250 Million Users

Executive Summary

ResMed's CEO Mick Farrell outlined the company's 2025 strategy: double-digit growth, drive up its user base to 250 million people and becoming the leading digital health company in both sleep apnea and chronic obstructive pulmonary (COPD) disease. Medtech Insight sat down with Farrell at ResMed's San Diego headquarters to learn more.

You may also be interested in...



ResMed Study Claims Nearly A Billion People Worldwide Have Sleep Apnea

A new multinational analysis by ResMed showed that the number of people with sleep apnea is 10 times higher than previous estimates by the World Health Organization, raising the need for developing strategies to raise awareness of the disease and diagnose and treat the disease.

Expert Panel Discusses Impact Of Stricter US, EU Data Privacy Laws On Medtech Industry

An expert panel at the AdvaMed Digital MedTech Conference discussed the impact of new privacy rights and data protection, in particular CCPA and GDPR, on medtech companies and ways for companies to deal with the challenge of compliance.

Market Snapshot: Global Sleep Apnea Management Market Will Reach $10.3Bn by 2022

The worldwide airway management accessories and sleep apnea management products market is expected to reach $10.3bn by 2022, a CAGR of 7.4%. This market is largely driven by the rising prevalence of age- and obesity-related respiratory disorders, the rising demand for at-home patient care and rapid growth of sleep apnea treatment device sales. The three major players are Philips Healthcare, ResMed and Drive DeVilbiss.

Related Content

Topics

Related Companies

UsernamePublicRestriction

Register

MT125607

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel